AURO-APIXABAN
AURO-APIXABAN
Approved
DIN Number
02486814
Drug Class
Human
Market Date
Nov 28, 2022
Company
HC
auro pharma inc
Product Information
Detailed information about this Health Canada approved drug product, including dosage form, route of administration, and regulatory classification.
Product Details
Health Canada regulatory and product classification information
Regulatory Identifiers
DIN Number02486814
AIG Number0153051002
Classification & Schedule
C
Drug Class
Human
S
Schedule
Prescription
A
ATC Code
B01AF02 APIXABAN
Product Specifications
Dosage FormTablet
Route of AdministrationOral
AHFS Classification20:12.04.14
Health Canada Classification
ACTIVE INGREDIENTS (1)
APIXABANActive
Strength: 5 MG
Monograph: APIXABAN